BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6573941)

  • 21. Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine.
    Murphy SB; Bowman WP; Abromowitch M; Mirro J; Ochs J; Rivera G; Pui CH; Fairclough D; Berard CW
    J Clin Oncol; 1986 Dec; 4(12):1732-9. PubMed ID: 3491184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Results of modified LSA2-L2 protocol with moderate-dose MTX therapy in children with untreated non-Hodgkin's lymphoma].
    Shimamoto Y; Imai S; Endo N
    Gan To Kagaku Ryoho; 1992 Mar; 19(3):395-8. PubMed ID: 1543367
    [No Abstract]   [Full Text] [Related]  

  • 23. Results of LSA2-L2 therapy in 26 children with non-Hodgkin's lymphoma.
    Pichler E; Jürgenssen OA; Radaszkiewicz T; Reinartz G; Mutz I; Urban C; Krepler P; Schmidmeier W; Becker H; Kundi M
    Cancer; 1982 Dec; 50(12):2740-6. PubMed ID: 6897203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved outcome in children with advanced stage B-cell non-Hodgkin's lymphoma (B-NHL): results of the United Kingdom Children Cancer Study Group (UKCCSG) 9002 protocol.
    Atra A; Imeson JD; Hobson R; Gerrard M; Hann IM; Eden OB; Carter RL; Pinkerton CR
    Br J Cancer; 2000 Apr; 82(8):1396-402. PubMed ID: 10780517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [non-Hodgkin's lymphoma treated with modified LSA2-L2 protocol--a clinical experience and case report].
    Chiou SS; Chang TT; Perng JJ; Chen TS
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1987 Jun; 3(6):419-24. PubMed ID: 3483004
    [No Abstract]   [Full Text] [Related]  

  • 26. Improved prognosis in children with intra-abdominal non-Hodgkin's lymphoma following LSA2L2 protocol chemotherapy.
    Wollner N; Wachtel AE; Exelby PR; Centore D
    Cancer; 1980 Jun; 45(12):3034-9. PubMed ID: 7388747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia].
    Guo J; Zhu YP; Gao J; Li Q; Jia CS; Zhou CY; Guo X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):72-9. PubMed ID: 26913397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-Hodgkin's lymphoma in children: results of treatment with the modified LSA2-L2 protocol.
    Vecchi V; Pession A; Serra L; Rosito P; Mancini AF; Paolucci G
    Med Pediatr Oncol; 1981; 9(5):483-91. PubMed ID: 7300804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multimodality therapy of favorable prognosis non-Hodgkin's lymphoma.
    Corder MP; Leimert JT; Tewfik HH; Lovett JM
    Int J Radiat Oncol Biol Phys; 1983 Jul; 9(7):1009-12. PubMed ID: 6345487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of acute lymphoblastic leukemia in children: modified LSA2-L2 therapy].
    Ishii E; Hara T; Ueda K; Kishida K; Nakamura E; Miyazaki S; Yoshida N
    Rinsho Ketsueki; 1985 Apr; 26(4):487-93. PubMed ID: 3862888
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of intensification and maintenance programs in the treatment of acute lymphoblastic leukemia.
    Sackmann-Muriel F; Svarch E; Eppinger-Helft M; Braier JL; Pavlovsky S; Guman L; Vergara B; Ponzinibbio C; Failace R; Garay GE; Bugnard E; Ojeda FG; De Bellis R; de Sijvarger SR; Saslavsky J
    Cancer; 1978 Oct; 42(4):1730-40. PubMed ID: 101296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-Hodgkin's lymphoma in children: a progress report on the original patients treated with the LSA2-L2 protocol.
    Wollner N; Exelby PR; Lieberman PH
    Cancer; 1979 Dec; 44(6):1990-9. PubMed ID: 389403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results of a randomized phase III trial in children and adolescents with advanced stage diffuse large cell non Hodgkin's lymphoma: a Pediatric Oncology Group study.
    Laver JH; Mahmoud H; Pick TE; Hutchinson RE; Weinstein HJ; Schwenn M; Weitzman S; Murphy SB; Ochoa S; Shuster JJ;
    Leuk Lymphoma; 2001 Jul; 42(3):399-405. PubMed ID: 11699405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin's lymphoma: a Childrens Cancer Group study.
    Tubergen DG; Krailo MD; Meadows AT; Rosenstock J; Kadin M; Morse M; King D; Steinherz PG; Kersey JH
    J Clin Oncol; 1995 Jun; 13(6):1368-76. PubMed ID: 7751881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Results of a randomized phase III trial in children and adolescents with advanced stage diffuse large cell non-Hodgkin's lymphoma: a Pediatric Oncology Group study.
    Laver JH; Mahmoud H; Pick TE; Hutchison RE; Weinstein HJ; Schwenn M; Weitzman S; Murphy SB; Ochoa S; Shuster JJ
    Leuk Lymphoma; 2002 Jan; 43(1):105-9. PubMed ID: 11908712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results of treatment with high intensity, brief duration chemotherapy in poor prognosis non-Hodgkin's lymphoma.
    McMaster ML; Greer JP; Wolff SN; Johnson DH; Greco FA; Stein RS; Cousar JB; Flexner JM; Hainsworth JD
    Cancer; 1991 Jul; 68(2):233-41. PubMed ID: 1712662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. End results of treating children with localized non-Hodgkin's lymphomas with a combined modality approach of lessened intensity.
    Murphy SB; Hustu HO; Rivera G; Berard CW
    J Clin Oncol; 1983 May; 1(5):326-30. PubMed ID: 6668503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Childhood non-Hodgkin's lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2).
    Anderson JR; Wilson JF; Jenkin DT; Meadows AT; Kersey J; Chilcote RR; Coccia P; Exelby P; Kushner J; Siegel S; Hammond D
    N Engl J Med; 1983 Mar; 308(10):559-65. PubMed ID: 6338381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-Hodgkin's lymphoma.
    Gulati SC; Gulati C; Vega R; Gandola L; Yopp J; Dinsmore R; O'Reilly R; Clarkson B
    Indian J Pediatr; 1983; 50(407):667-74. PubMed ID: 6389331
    [No Abstract]   [Full Text] [Related]  

  • 40. Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5.
    Sieber M; Tesch H; Pfistner B; Rueffer U; Lathan B; Brosteanu O; Paulus U; Koch T; Pfreundschuh M; Loeffler M; Engert A; Josting A; Wolf J; Hasenclever D; Franklin J; Duehmke E; Georgii A; Schalk KP; Kirchner H; Doelken G; Munker R; Koch P; Herrmann R; Greil R; Anselmo AP; Diehl V
    J Clin Oncol; 2002 Jan; 20(2):476-84. PubMed ID: 11786577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.